Coronavirus: Cases in UK jump to 87

The UK reports its largest daily increase in cases, as two patients on a hospital ward are diagnosed.

Share Button

Health24.com | Being bullied about weight may raise risk of drug use

Teens who are bullied about their weight are at increased risk for alcohol or marijuana use – and this is especially true for girls, a new study suggests.

Researchers surveyed more than 1 300 students at five public middle schools in Connecticut. The students were asked if siblings, parents or peers had teased them about their weight, body shape or eating during the past six months.

More than half (55%) reported weight-related teasing, including 76% of overweight girls, 71% of overweight boys, 52% of girls who weren’t overweight, and 43% of boys who weren’t overweight.

Frequent teasing about weight was associated with higher levels of overall alcohol use, binge drinking and marijuana use, though the study could not prove a cause-and-effect link.

Bullying incredibly common

A follow-up survey six months later found that weight-related teasing remained linked to increased alcohol use and binge drinking, according to the study published online recently in the journal Psychology of Addictive Behaviors.

“This type of bullying is incredibly common and has many negative effects for adolescents,” said lead study author Melanie Klinck, a clinical research assistant at the University of Connecticut.

The association between appearance-related teasing and substance use was strongest among overweight girls, the researchers said.

“These findings raise larger issues about how society places too much emphasis on beauty and body image for girls and women, and the damaging effects that may result,” said study co-author Christine McCauley Ohannessian, director of the Center for Behavioral Health at Connecticut Children’s Medical Center.

“Schools and communities should specifically address appearance-related teasing in anti-bullying policies and substance-use interventions,” she said in a journal news release.

“Parents particularly have a role to play in addressing this issue. There is some startling research showing that some of the most hurtful examples of weight-based teasing come from parents or siblings, so families should be kind when they discuss the weight of their children,” Ohannessian added.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Health24.com | Can you spread coronavirus even after you have recovered?

The World Health Organization (WHO) recently reported that, even though Covid-19 virus should be taken seriously, 80% of the cases are mild and completely treatable.

However, a small study from China now suggests that the new coronavirus may linger in the body for at least two more weeks after the symptoms of the disease have disappeared.

This is no reason for panic according to experts. There are many viruses that can still linger in the body after symptoms have cleared, and it seems that the patients are less contagious post-symptom than they were before they started showing symptoms.

According to Krys Johnson, an epidemiologist at Temple University’s College of Public health, the findings are not entirely bad news. “Viruses that tend to hang around in people’s systems also tend to be the viruses that the body develops a strong immunity response against,” he told Live Science.

What did the research entail?

The new study was published in the journal JAMA. The researchers followed four medical professionals between the ages of 30 and 36 who developed the Covid-19 virus and were treated at Wuhan University’s Zhongnan Hospital.

All the patients completely recovered after the illness and only one was hospitalised during the illness.

The patients were treated with the existing antiviral oseltamivir (also known as Tamiflu), which is usually used to treat influenza. After their symptoms cleared up, they were considered recovered and they tested negative for the Covid-19 virus twice on two consecutive days.

The patients were still ordered to quarantine themselves at home for five days. They continued to undergo swabs for the Covid-19 virus after five days for up to 13 days after recovery. On every test day between day five and day 13, the tests were, however, positive.

“These findings suggest that at least a proportion of recovered patients still may be virus carriers,” the researchers wrote. 

Can you catch the Covid-19 virus twice?

At the same time, Japan reported a case of someone who recovered from the Covid-19 virus, only to become ill and test positive for the virus for a second time.

Experts were not clear on this case – some reckon that the patient caught a new version of the virus. Others tend to think that the patient’s own system didn’t fight off the virus completely, and it replicated inside the lungs again, causing symptoms for a second time.

Other viruses that linger

As mentioned before, it’s not new for viruses to linger in the body at low levels after recovering from symptoms. Ebenezer Tumban, a virologist at Michigan Tech University, mentions the Zika and Ebola virus as examples.

Tumban reckons that the Covid-19 virus in the patients started to replicate at a low level after the antiviral medication was stopped. As the virus was low level, there was not enough of it to cause symptoms again, and the patients were not even likely to be very contagious.

“They should be careful in the household setting not to share drinks and make sure they’re washing their hands frequently,” she said. “But if they’re just a carrier, they shouldn’t be able to transmit outside of that close contact of shared beverage and food,” stated Johnson.

READ | What is the difference between Covid-19 and coronavirus?

READ | Coronavirus 101 – what you need to know 

Image credit: iStock

Share Button

Women in labour refused epidurals, government finds

Claims that stretched resources and a lack of information for women mean some are being denied.

Share Button

Health24.com | Coronavirus 101 – what you need to know

Since news of the new coronavirus broke early January, cases have escalated worldwide. And as news broke of the first sub-Saharan case identified in Nigeria, two South Africans on a cruise ship in Japan, and 151 South Africans living in Wuhan who are about to be evacuated back to South Africa, the impact is being felt closer to home.

But in a time of sensational news headlines and increasing numbers of infections worldwide, it’s important to go back to basics. Here are the answers to the most common questions:

1. What are the first symptoms?

These are the most common symptoms listed by the World Health Organisation (WHO) most likely to be experienced first:

  • Fever
  • Fatigue
  • Dry cough

Other symptoms may include:

  • Muscle aches
  • Nasal congestion
  • Sore throat
  • Diarrhoea (not as common but reported in 3.7% of cases)

2. If it starts off mild, why do people die?

While about 80% of people suffer mild cases, older people (over 60) and those with underlying conditions such as  hypertension, diabetes, cancer, heart conditions or pre-existing lung conditions are more likely to become severely ill and die from respiratory failure.

3.  Will I get it?

The WHO reports that your risk depends on where you live or where you have travelled to recently, as the risk is higher in areas where numbers of people have already been diagnosed with the coronavirus.

So, if you are currently in South Africa and haven’t travelled to affected areas, your risk remains low. 

4.  How do I prevent it?

And what if indeed you are traveling to or living in an affected area? The best way to prevent it is to practice proper hygiene. That means going back to basics and regularly washing your hands thoroughly with soap, or an alcohol sanitiser. Cough or sneeze into the crook of your elbow.

Also refrain from touching your face and eyes with unwashed hands.

If you are currently wondering about the effectiveness of masks, the WHO states that only those who are already coughing and sneezing, or taking care of others who are coughing and sneezing, should wear a mask.

5. What if I get it?

If you have travelled to an affected area recently or have been in close contact with someone who has travelled to an affected area, go and see a doctor immediately if you experience any symptoms, however mild.

The National Institute for Communicable Diseases (NICD) has a comprehensive list of countries that are high risk and handy contact numbers if you should have any other queries. 

READ| 5 things you should know about the latest strain of coronavirus 

READ | Coronavirus enigma: Experts ask why Africa seems to have few cases

READ | The new coronavirus is striking men and older people at a greater rate

Image credit: Unsplash

Share Button

Coronavirus: Hospital patients to be seen via video link

Move to reduce the transmission of coronavirus in hospitals comes as hand-washing ad campaign begins.

Share Button

Coronavirus: How do I protect myself?

The BBC Health team talks through the NHS advice about protecting yourself from COVID-19.

Share Button

Chest CT findings in coronavirus disease (COVID-19) pneumonia

A multi-center study (n=101) of the relationship between chest CT findings and the clinical conditions of coronavirus disease (COVID-19) pneumonia — published ahead-of-print and open-access in the American Journal of Roentgenology (AJR) — determined that most patients with COVID-19 pneumonia have ground-glass opacities (GGO) (86.1%) or mixed GGO and consolidation (64.4%) and vascular enlargement in the lesion (71.3%).

In addition, lead authors Wei Zhao, Zheng Zhong, and colleagues revealed that lesions present on CT images were more likely to have peripheral distribution (87.1%) and bilateral involvement (82.2%) and be lower lung predominant (54.5%) and multifocal (54.5%).

Zhao, Zhong, et al. collected their 101 cases of COVID-19 pneumonia across four institutions in China’s Hunan province, comparing clinical characteristics and imaging features between two groups: nonemergency (mild or common disease) and emergency (severe or fatal disease).

Accordingly, most of the cohort (70.2%) were 21-50 years old, and most patients (78.2%) had fever as the onset symptom. Only five patients showed disease associated with a family outbreak.

While the emergency group patients were older than the patients in the nonemergency group, the rate of underlying disease was not significantly different in the two groups — suggesting that viral load could be a better reflection of the severity and extent of COVID-19 pneumonia.

As Zhao and Zhong explained further: “Architectural distortion, traction bronchiectasis, and pleural effusions, which may reflect the viral load and virulence of COVID-19, were statistically different between the two groups and may help us to identify the emergency type disease.”

The authors of this AJR article also noted that CT involvement score can help evaluate the severity and extent of COVID-19 pneumonia.

Story Source:

Materials provided by American Roentgen Ray Society. Note: Content may be edited for style and length.

Share Button

The brains of shrimps and insects are more alike than we thought

New research shows that crustaceans such as shrimps, lobsters and crabs have more in common with their insect relatives than previously thought — when it comes to the structure of their brains.

Both insects and crustaceans possess mushroom-shaped brain structures known in insects to be required for learning, memory and possibly negotiating complex, three-dimensional environments, according to the study, led by University of Arizona neuroscientist Nicholas Strausfeld.

The research, published in the open-access journal eLife, challenges a widely held belief in the scientific community that these brain structures — called “mushroom bodies” — are conspicuously absent from crustacean brains.

In 2017, Strausfeld’s team reported a detailed analysis of mushroom bodies discovered in the brain of the mantis shrimp, Squilla mantis. In the current paper, the group provides evidence that neuro-anatomical features that define mushroom bodies — at one time thought to be an evolutionary feature proprietary to insects — are present across crustaceans, a group that includes more than 50,000 species.

Crustaceans and insects are known to descend from a common ancestor that lived about a half billion years ago and has long been extinct.

“The mushroom body is an incredibly ancient, fundamental brain structure,” said Strausfeld, Regents Professor of neuroscience and director of the University of Arizona’s Center for Insect Science. “When you look across the arthropods as a group, it’s everywhere.”

In addition to insects and crustaceans, other arthropods include arachnids, such as scorpions and spiders, and myriapods, such as millipedes and centipedes.

Characterized by their external skeletons and jointed appendages, arthropods make up the most species-rich group of animals known, populating almost every conceivable habitat. About 480 million years ago, the arthropod family tree split, with one lineage producing the arachnids and another the mandibulates. The second group split again to provide the lineage leading to modern crustaceans, including shrimps and lobsters, and six-legged creatures, including insects — the most diverse group of arthropods living today.

Decades of research has untangled arthropods’ evolutionary relationships using morphological, molecular and genetic data, as well as evidence from the structure of their brains.

Mushroom bodies in the brain have been shown to be the central processing units where sensory input converges. Vision, smell, taste and touch all are integrated here, as studies on honeybees have shown. Arranged in pairs, each mushroom body consists of a column-like portion, called the lobe, capped by a dome-like structure, called the calyx, where neurons that relay information sent from the animal’s sensory organs converge. This information is passed to neurons that supply thousands of intersecting nerve fibers in the lobes that are essential for computing and storing memories.

Recent research by other scientists has also shown that those circuits interact with other brain centers in strengthening or reducing the importance of a recollection as the animal gathers experiences from its environment.

“The mushroom bodies contain networks where interesting associations are being made that give rise to memory,” Strausfeld said. “It’s how the animal makes sense of its environment.”

A more evolutionarily “modern” group of crustaceans called Reptantia, which includes many lobsters and crabs, do indeed appear to have brain centers that don’t look at all like the insect mushroom body. This, the authors suggest, helped create the misconception crustaceans lack the structures altogether.

Brain analysis of crustaceans has revealed that while the mushroom bodies found in crustaceans appear more diverse than those of insects, their defining neuroanatomical and molecular elements are all there.

Using crustacean brain samples, the researchers applied tagged antibodies that act like probes, homing in on and highlighting proteins that have been shown to be essential for learning and memory in fruit flies. Sensitive tissue-staining techniques further enabled visualization of mushroom bodies’ intricate architecture.

“We know of several proteins that are necessary for the establishment of learning and memory in fruit flies,” Strausfeld said, “and if you use antibodies that detect those proteins across insect species, the mushroom bodies light up every time.”

Using this method revealed that the same proteins are not unique to insects; they show up in the brains of other arthropods, including centipedes, millipedes and some arachnids. Even vertebrates, including humans, have them in a brain structure called the hippocampus, a known center for memory and learning.

“Corresponding brain centers — the mushroom body in arthropods, marine worms, flatworms and, possibly, the hippocampus of vertebrates — appear to have a very ancient origin in the evolution of animal life,” Strausfeld said.

So why do the most commonly studied crustaceans have mushroom bodies that can appear so drastically different from their insect counterparts? Strausfeld and his co-authors have a theory: Crustacean species that inhabit environments that demand knowledge about elaborate, three-dimensional areas are precisely the ones whose mushroom bodies most closely resemble those in insects, a group that has also mastered the three-dimensional world by evolving to fly.

“We don’t think that’s a coincidence,” Strausfeld says. “We propose that that the complexity of inhabiting a three-dimensional world may demand special neural networks that allow a sophisticated level of cognition for negotiating that space in three dimensions.”

Lobsters and crabs, on the other hand, spend their lives confined mostly to the seafloor, which may explain why they’ve historically been said to lack mushroom bodies.

“At the risk of offending colleagues who are partial to crabs and lobsters: I view many of these as flat-world inhabitants,” Strausfeld says. “Future studies will be able to tell us which are smarter: the reef dwelling mantis shrimp, a top predator, or the reclusive lobster.”

Strausfeld co-authored the paper with two of his former students — Gabriella Wolff, now a post-doctoral fellow at the University of Washington, and Marcel Sayre, now a doctoral student at Lund University in Sweden. They hope that the study of mushroom bodies will further help in resolving how brains may have evolved and what environmental conditions shaped that process.

“This research moves us closer to answering the ultimate question,” Strausfeld says. “We want to know: What was the earliest brain like?”

Share Button

Improved CRISPR gene drive solves problems of old tech

Gene drives use genetic engineering to create a desired mutation in a few individuals that then spreads via mating throughout a population in fewer than 10 generations.

In theory, such a mechanism could be used to prevent malarial mosquitoes from transmitting disease, or possibly to wipe out an invasive species by disabling its ability to reproduce.

Though scientists have had success proving the concept in the lab, they have found that wild populations invariably adapt and develop resistance to the scheme. And when gene drives work, they are all or nothing — without nuance — they spread to all individuals, which can be a drawback.

Now, a Cornell study, “A Toxin-Antidote CRISPR Gene Drive System for Regional Population Modification,” published Feb. 27 in the journal Nature Communications, describes a new type of gene drive with the potential to delay resistance. The method could also be applied to a regional population, limiting its spread other populations where it could have undesired effects.

“Those are two things that this new drive that we developed here addresses to some extent,” said Philipp Messer, an assistant professor of computational biology, and the paper’s senior author. Jackson Champer, a postdoctoral researcher in Messer’s lab, is the first author.

In a classic gene drive, called a homing drive, an offspring inherits one set of genes, or genome, from the mother and another from the father. If an offspring inherits a gene with a drive from one parent and not the other, the drive copies itself into the genome from the parent without the drive.

“Now that individual has that drive in both of its genomes and it will pass it on to every offspring,” Messer said.

The drives are engineered with CRISPR-Cas9 gene-editing technology, so when the drive copies itself into a new genome, the CRISPR machinery makes a cut into the chromosome without the drive, and pastes in the new code. But sometimes, cells will repair the incision and, in doing so, randomly delete DNA letters. When this happens, the CRISPR gene drive can no longer find a genetic sequence it recognizes in order to make the incision, which creates a resistance and stops the gene drive from spreading.

Natural genetic variation — another source of changes in DNA sequences — can also create resistance, since CRISPR gene drives must recognize short genetic sequences in order to make incisions.

“We were among the first labs to show that this is a tremendous problem,” Messer said.

The paper describes a new gene drive, called TARE (Toxin-Antidote Recessive Embryo), which works by targeting a gene that is essential for an organism to function. At the same time, the organism can survive with only one intact copy of this essential gene. Instead of cutting and pasting DNA as homing drives do, the TARE drive simply cuts the other parent’s gene, disabling it.

Meanwhile, the engineered TARE drive gene has a DNA sequence that has been recoded; the gene works but it won’t be recognized or cut in future generations. If an offspring inherits two disabled genes, those individuals won’t survive, thereby removing those copies from the population. Meanwhile, as viable individuals mate, more and more surviving offspring will carry TARE drive genes.

Just a few individuals with homing drives can spread a trait through an entire population. TARE drives, on the other hand, do not cut and paste a drive into a target gene; instead they destroy one of the target gene copies in the offspring. Because of this, the drive requires a higher frequency of engineered individuals in the population to spread. For this reason, TARE drives are less likely to transfer from one distinct population to another.

In lab experiments, when fruit flies with TARE gene drives were released in cages of wild-type fruit flies, all the flies in the cage had the TARE drive in just six generations.

The researchers pointed out that resistance can indeed evolve with a TARE drive in the wild, especially in very large populations, but they believe it will take longer and evolve at a much lower rate, Messer said.

Also contributing was Andrew Clark, professor of computational biology and molecular biology and genetics. The research was funded by the National Institutes of Health.

Share Button